Skip to main content

News

Travel During COVID-19 Pandemic

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Copay Assistance Programs Help Patients but Confuse Them Too

MedPage Today

"If you're having trouble paying for your medications, Drug Company X may be able to help."

RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...

2020 Rheumatology Year in Review

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.

ProDERM Study: IVIG in Dermatomyositis

The ProDERM study design and outcomes are previewed in Medicine; and as promised the results were revealed at ACR Convergence in November 2020 showing that IVIg is safe, effective and superior to placebo i(PBO) in patients with dermatomyositis (DM).

Long Term Safety and Efficacy of Tacrolimus in Lupus Nephritis

Takeuchi et al has published their large experience with long-term tacrolimus use in lupus nephritis patients showing its real-world safety and efficacy.

Delays in Diagnosis of Axial Spondyloarthritis

The diagnosis of axial spondyloarthritis (and anklylosing spondylitis) (axSpA) is often delayed and usually not diagnosed by rheumatologists; a recent metanalysis shows that longer delays were attributable to lower education levels, younger age at onset and absence of extra-articular manifestatio

Hydroxychloroquine Shortage During COVID-19

According to a recent report in Annals of Rheumatic Disease, public enthusiasm for hydroxychloroquine (HCQ) created significant access issues for rheumatic patients in the early phases of the COVID-19 pandemic.

Adipose Transplants as a New Regulator of Osteoarthritis

A novel report from PNAS suggests that in osteoarthritis (OA), the damage is not entirely from body weight and mechanics, instead it may be from adipose tissue itself.

Corticosteroid Use Hikes CV Risks in Rheumatic Patients

UK Clinical Practice Research Datalink population study shows that patients with immune-mediated inflammatory diseases, such as RA, PMR, GCA and IBD, have an augmented risk of CV outcomes with glucocorticoid use; even lower doses had a near doubling of their underlying CVD risk.

Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo

MedPage Today

The fate of the Trump administration's "most favored nation" (MFN) rule for bringing down prescription drug prices remains uncertain as President-elect Joe Biden prepares to assume office later this month.

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.
×